| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Vuori Kristiina Md serves as a Director at INBX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 4 buys and 0 sells. Those positions are worth an estimated $307K at current prices.
Historically, Vuori Kristiina Md's trades have earned a strong insider score of 76/100 across 4 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +93.0%.
The biggest single holding is INBX (~$307K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 20,443 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2024 | INBX Inhibrx Biosciences, Inc. | Director | Buy | 6,667 | $15.00 | $100,005.00 | +48.4% | +2.5% | +139.6% | |
| Sep 11, 2024 | INBX Inhibrx Biosciences, Inc. | Director | Buy | 6,636 | $15.07 | $99,991.99 | +92.9% | -0.2% | +89.7% | |
| Aug 29, 2024 | INBX Inhibrx Biosciences, Inc. | Director | Buy | 7,140 | $14.00 | $99,960.00 | New | +12.4% | +102.7% |